Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
BMJ Open|December 30, 2025
Multicentre prospective non-interventional study protocol for evaluating surgical strategies for Colorectal Resections and Postoperative Quality of Life in Retroperitoneal Sarcoma Patients Across German-Speaking Sarcoma Centres (COLOSARC-Q)Madelaine Hettler, Katrin R Scharpf, Anna Eich, et al.
Langenbeck'S Archives of Surgery|August 14, 2017
Synchronous colorectal liver metastases: focus on the elderly : An Effectiveness Study from Routine CareMarkus Albertsmeier, Andrea Engel, Markus O Guba, et al.
Langenbeck'S Archives of Surgery|December 21, 2011
Evaluation of the safety and efficacy of MonoMax® suture material for abdominal wall closure after primary midline laparotomy-a controlled prospective multicentre trial: ISSAAC [NCT005725079]Markus Albertsmeier, Christoph M Seiler, Lars Fischer, et al.
Anti-Cancer Drugs|March 19, 2014
Complete pathological response to neoadjuvant pemetrexed/cisplatin in combination with regional hyperthermia in a patient with sarcomatoid peritoneal mesotheliomaStephan Kruger, Martin K Angele, Simone Reu, et al.
Journal of Surgical Oncology|March 8, 2021
Chances, challenges and outcomes of patients with complex bilobar colorectal liver metastases approached by a combined multimodal therapy with liver resection and local ablative therapyMoritz Drefs, Markus B Schoenberg, Tobias S Schiergens, et al.
Annals of Surgical Oncology|August 29, 2025
Surgery for Retroperitoneal Soft Tissue Sarcoma is Safe Following Multimodal Treatment with Regional HyperthermiaMathilda Knoblauch, Cathy Werdel, Yanik Arlt, et al.
Molecular Therapy Oncolytics|January 13, 2022
A novel immune-related gene signature predicting survival in sarcoma patientsHaoyu Ren, Alexandr V Bazhin, Elise Pretzsch, et al.
Cancers|October 13, 2021
Expression Patterns of TOP2A and SIRT1 Are Predictive of Survival in Patients with High-Risk Soft Tissue Sarcomas Treated with a Neoadjuvant Anthracycline-Based ChemotherapyLuc M Berclaz, Annelore Altendorf-Hofmann, Hans Roland Dürr, et al.
Cancers|February 25, 2022
VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?Markus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Cancers|December 8, 2020
Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue SarcomaMarkus Albertsmeier, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
Pageof 8